- Market cap
- Revenue
- Net income
- Cash on hand
- Gross margin
- Net margin
- EPS
- P/E ratio
Aetna joins Humana and United Healthcare in providing Medicare Advantage coverage for beneficiaries who meet medical necessity criteria for the ReWalk Personal Exoskeleton Together, these three national Medicare Advantage insurers represent approximately 16 million beneficiaries across the United States  […] The post Lifeward’s ReWalk Personal Exoskeleton Now Covered by Aetna, Coverage Expands to Include Three of the Largest Medicare Advantage Insurers appeared first on Lifeward.
Positions Lifeward as a MedTech platform with a clear path to cashflow positive and long-term Biotech upside potential MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Jan. 13, 2026 (GLOBE NEWSWIRE) — Lifeward Ltd., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global […] The post Lifeward Enters Transformative Strategic Investment and Partnership Agreement with Oramed to Create a Diversified Biomedical Innovation Company appeared first on Lifeward.
Medicare Advantage claim processed in less than thirty days Additional progress with traditional Medicare claim approvals has accelerated timelines to payment in 2025 MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, September 9, 2025 – Lifeward Ltd., […] The post First Commercial Medicare Advantage Plan Provides Payment for ReWalk 7 Personal Exoskeleton appeared first on Lifeward.
Seventh generation of industry-leading ReWalk Exoskeleton is now cleared for commercial launch in the European Union MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, September 8, 2025 – Lifeward Ltd., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a […] The post Lifeward Achieves CE Mark Approval for the ReWalk 7 Personal Exoskeleton appeared first on Lifeward.
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, August 13, 2025 (GLOBE NEWSWIRE) — Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical […] The post Lifeward Names Almog Adar as New CFO, Strengthening Executive Leadership appeared first on Lifeward.
Decision at the highest levels of appeal in the Medicare process establishes medical necessity of the ReWalk Exoskeleton for enabling paralyzed individuals to stand and walk in everyday environments. MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, […] The post Administrative Law Judge Determines ReWalk Personal Exoskeleton is “Reasonable and Necessary” for Medicare Beneficiary appeared first on Lifeward.
Industry veteran brings 30 years of commercial leadership experience MARLBOROUGH, MA, and YOKNEAM ILLIT, Israel, May 19, 2025 – Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform […] The post Lifeward Names Mark Grant as New CEO appeared first on Lifeward.
Approval signals important progress in U.S. market expansion as major commercial health insurers begin to follow precedent set with Medicare reimbursement for personal exoskeletons established in 2024 Decision to cover device arrives shortly after the […] The post First Major U.S. Commercial Health Insurer Approves Purchase of ReWalk 7 Personal Exoskeleton appeared first on Lifeward.
Cooperation between Lifeward and Beilinson Hospital marks the first step towards a national policy in Israel on Exoskeleton training and procurement MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, April 24, 2025 –  Lifeward Ltd., (Nasdaq: LFWD) […] The post Paralyzed Israeli Soldier Walks Again with Use of the ReWalk Personal Exoskeleton appeared first on Lifeward.
